Ashland Inc. (NYSE:ASH) Receives Consensus Rating of "Moderate Buy" from Brokerages
Ashland Inc. (NYSE:ASH) has received a "Moderate Buy" consensus rating from twelve brokerages, with an average 12-month price target of $73.90. Institutional investors hold a significant 93.95% of Ashland's shares, and the company recently declared a quarterly dividend of $0.42 per share, yielding 2.3%. The stock opened at $73.33, trading above its 200-day moving average.
Massachusetts Financial Services (ASH) discloses 4.5% Ashland Inc. stake
Massachusetts Financial Services Company has filed an amended Schedule 13G, disclosing a beneficial ownership of 4.5% in Ashland Inc. common stock as of June 30, 2026. This translates to 2,037,663 shares, with MFS holding sole voting power over 2,032,989 shares and sole dispositive power over all reported shares, indicating a passive investment below the 5% threshold.
Ashland Inc. (ASH) SVP converts 1,806 RSUs; 526 shares withheld for taxes
Ashland Inc.'s SVP, GC & Secretary, Robin E. Lampkin, converted 1,806 Restricted Stock Units (RSUs) into common shares on August 11, 2026. A total of 526 shares were withheld at $74.58 each to cover tax liabilities. This transaction also corrected a previous report regarding the initial RSU grant.
Leon Cooperman Buys Ashland Inc (ASH) -- Shares Look 9% Overvalued on GF Value
Leon Cooperman's Omega Advisors significantly increased its stake in Ashland Inc (ASH) by adding 1,215,000 shares, bringing his total holdings to 2,915,000 shares, representing 6.77% of his portfolio and 6.40% of Ashland's outstanding shares. Despite this strong vote of confidence, GuruFocus's GF Value model suggests Ashland shares are currently about 9% overvalued at $74.58 compared to an intrinsic value of $68.64. The company, a specialty materials leader, shows strong financial health with a Piotroski F-Score of 8 but faces operational headwinds with negative revenue and earnings growth.
Ashland Inc. Updates Board Committee Roles for Newly Appointed Directors Spizzo and Thomas
Ashland Inc. has announced updates to its Board of Directors' committee assignments for new directors Allen A. Spizzo and Peter T. Thomas, effective August 7, 2026. This information was disclosed in an amended current report filed on August 10, 2026. The article indicates that further details are available upon logging in or creating an account.
Ashland Explores Potential Sale Following Takeover Interest
Specialty ingredients supplier Ashland is reportedly considering a potential sale after attracting takeover interest from various strategic and financial buyers, including private equity firms like Advent, Apollo, and Carlyle, as well as major shareholder Standard Industries. The company is working with Citigroup and Lazard to evaluate these approaches, following pressure from activist investor Ancora Holdings Group to pursue a sale. A change of ownership would significantly impact the beauty and personal care ingredients sector, reflecting broader investor interest in high-value specialty chemical businesses.
Ashland may be worth low/mid-$90/shr in takeover - analyst
An analyst suggests that Ashland Inc. (ASH) could be valued in the low to mid-$90s per share in a potential takeover scenario. This valuation follows a report indicating the chemicals maker is considering a sale due to receiving takeover interest. The analyst's assessment takes into account execution challenges and market behaviors.
Is Ashland (ASH) Using Its New Advisory Committee to Quietly Redefine Capital Allocation Priorities?
Ashland Inc. (ASH) recently announced a quarterly dividend and formed a Capital Allocation Advisory Committee after reaching an agreement with Ancora Holdings Group. This committee, along with two new independent directors, could significantly influence Ashland's investment strategies and how it balances reinvestment with shareholder returns, especially given potential risks to margins and competitiveness. The article explores how these changes might affect the company's financial outlook and existing investment narratives.
Ashland Sets Sept. 15 Date to Pay Quarterly Cash Dividend
Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.42 per share on its common stock. The dividend is payable on September 15, 2026, to shareholders of record as of the close of business on September 1, 2026. As of July 31, 2026, there were 45,805,711 common shares outstanding.
Ashland board authorizes quarterly dividend
Ashland Inc.'s board of directors has declared a quarterly cash dividend of $0.42 cents per share on its common stock. The dividend is payable on September 15, 2026, to stockholders of record as of September 1, 2026. As of July 31, 2026, there were 45,805,711 shares of Ashland common stock outstanding.
Ashland board authorizes quarterly dividend
Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.42 cents per share on its common stock. This dividend will be payable on September 15, 2026, to stockholders of record as of September 1, 2026. As of July 31, 2026, there were 45,805,711 shares of Ashland common stock outstanding.
Ashland jumps on report it's exploring sale after takeover interest
Ashland Inc. (ASH) shares rose 6% following a report that the chemical maker is exploring a potential sale after receiving takeover interest. The company is reportedly collaborating with Citigroup and Lazard to engage with both strategic and private equity firms regarding a possible acquisition.
Ashland Inc. Stock 12‑Month Price Target Raised to $79.91, Implies 11% Upside
Ashland Inc.'s average 12-month price target has been increased to $79.91, up from $78.09, based on estimates from 11 analysts. This new target suggests an 11% potential upside from its August 5th closing price. The consensus rating for ASH remains a "Buy" among 12 analysts, with 9 recommending Buy and 3 recommending Hold.
Ashland Inc. (NYSE: ASH) director Allen A. Spizzo files initial Form 3
Ashland Inc. director Allen A. Spizzo has filed an initial Form 3, signaling his status as an insider director of the company. The filing indicates no equity transactions or holdings and includes a Power of Attorney. This form serves as an initial statement of beneficial ownership, setting the stage for future insider trading reports.
Price to earnings forward of Ashland Inc. – MUN:AHT
This article provides financial information for Ashland Inc. (MUN:AHT) on the Munich Stock Exchange, specifically focusing on its forward price-to-earnings ratio. It indicates that the market is currently closed with no trades recorded for the company. The content also mentions the data sources used and various features available on the TradingView platform.
Ashland Inc. (ASH) gains 6.4% stake holder as Leon G. Cooperman reports 2.9M shares
Leon G. Cooperman, through Omega Capital Partners, L.P., has reported a beneficial ownership of 2,915,000 shares of Ashland Inc. common stock, representing a 6.4% stake in the company. This disclosure was made via a Schedule 13G filing, indicating a passive investment. Cooperman holds sole voting and dispositive power over these shares, which were calculated based on 45,793,370 shares outstanding as of June 30, 2026.
Ashland Inc. (ASH) Investigation: Bronstein, Gewirtz & Grossman
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ashland Inc. (ASH) securities. This investigation follows Ashland's Q2 2026 financial results, which missed analyst estimates due to "operational challenges" at its Hopewell manufacturing facility and updated full-year guidance reflecting these issues, leading to a significant drop in its stock price. Investors are encouraged to contact the firm to learn more about the investigation and assist with potential class action lawsuits.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Ashland Inc. (ASH) And Encourages Shareholders to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Ashland Inc. (ASH) following a significant drop in its stock price. The investigation stems from Ashland's Q2 2026 financial results, which missed analyst estimates, and the company's updated full-year guidance citing "operational challenges" at its Hopewell manufacturing facility and softer demand. Shareholders who purchased Ashland securities are encouraged to connect with the firm to assist in the investigation.
Ashland Number of Employees 2026 | Employee Count & Headcount Data
Ashland, Inc. (ASH) has approximately 2,931 employees worldwide as of March 2026, marking a 1.4% decline since 2023. The company is actively hiring with 132 job postings in 2026, a 12.9% increase from 2025. North America accounts for the largest share of its workforce (59.3%) and the highest median salaries, while overall employee sentiment is negative and declining.
Ashland (ASH) Stock Can Cash Flow Ease Lingering Margin Doubts?
Ashland (ASH) saw a mild stock pullback despite reporting Q3 2026 adjusted EPS of US$1.02 and US$103m in free cash flow, with over 90% conversion. While its core consumer
Ashland Extends $70 Million Receivables Securitization Facility to 2028 With PNC
Ashland (ASH) has extended its $70 million accounts receivable securitization facility with PNC Bank until July 28, 2028, through a Fifth Amendment to its Receivables Purchase Agreement. The amendment, signed on July 30, 2026, updates terms to current market standards and allows Ashland to maintain liquidity by monetizing eligible receivables through a bankruptcy-remote SPE.
Enterprise value to revenue forward of Ashland Inc. – NYSE:ASH
This article provides financial data specifically focusing on the enterprise value to revenue forward for Ashland Inc. (NYSE: ASH). It presents a table showing the period, value, change, and percentage change for this financial metric, indicating that this data was "Made by humans."
Ashland Inc. 2026 Q3 - Results - Earnings Call Presentation (NYSE:ASH) 2026-07-31
Ashland Inc. (NYSE: ASH) has published its slide deck in conjunction with its 2026 Q3 earnings call. The company reported an EPS of $1.02, beating estimates by $0.04, and revenue of $497.00M, exceeding expectations by $11.02M, despite a 7.34% year-over-year decrease.
Enterprise value to revenue forward of Ashland Inc. – SWB:AHT
The article provides a title indicating a focus on Ashland Inc.'s enterprise value to forward revenue, associated with its stock symbol SWB:AHT on the Stuttgart Stock Exchange. The content primarily consists of navigation and footer information from the TradingView platform, without providing specific financial data or analysis for Ashland Inc. The article serves as a placeholder or initial entry for financial data that is not yet populated.
Vanguard Portfolio Management (ASH) reports 2.48M-share Ashland Inc position
Vanguard Portfolio Management LLC and its affiliates have reported a beneficial ownership of 2,482,141 shares of Ashland Inc. common stock, representing a 5.42% stake as of June 30, 2026. This disclosure was made via a Schedule 13G filing, indicating a passive investment. Vanguard holds sole dispositive power over all these shares and sole voting power over 19,303 shares.
Ashland Inc (ASH) Q3 2026 Earnings Call Highlights: Strong Sales Growth Amidst Profitability ...
Ashland Inc. (ASH) reported strong sales growth of 7% year-over-year in Q3 2026, driven by volume gains across all business units, particularly in Life Sciences and Personal Care. Despite this, profitability was impacted by production challenges and lower tax credits, leading to a decrease in adjusted EBITDA and a revised EPS outlook. The company is focusing on manufacturing optimization and value pricing to address cost pressures and improve future margins.
Ashland Inc. (NYSE: ASH) SVP exercises 9,793 SARs, gains 1,267 shares
Ashland Inc.'s SVP and CTO, Osama M. Musa, exercised 9,793 Stock Appreciation Rights (SARs) at $57.96 per share, resulting in the acquisition of 1,267 common shares. This transaction, conducted under a Rule 10b5-1 trading plan, increased his direct holdings to 30,806 shares. The SARs were granted under the company's 2021 Omnibus Incentive Compensation Plan and settled on a net-share basis.
Ashland Inc. 3Q 2026: Revenue $497M, EPS $0.35— 10-Q Summary
Ashland Inc. reported strong third-quarter 2026 results with revenue of $497 million, a 7.3% increase year-over-year, and diluted EPS of $0.35, a significant turnaround from a loss in the prior-year quarter due to the absence of a goodwill impairment. The company saw growth driven by Life Sciences and Personal Care, with 73% of sales outside North America, and is progressing with a manufacturing network optimization program aimed at substantial pre-tax savings.
Ashland Inc (ASH) Q3 2026 Earnings Call Highlights: Strong Sales Growth Amidst Profitability ...
Ashland Inc (ASH) reported strong third-quarter 2026 sales growth of 7% year-over-year, driven by volume increases across all business units, particularly in Life Sciences and Personal Care. Despite this, profitability was impacted by production challenges and cost pressures, leading to a decrease in Adjusted EBITDA and a revised, lower Adjusted EPS outlook. The company is focusing on manufacturing optimization and value pricing to improve future margins and expects benefits from these efforts starting in fiscal 2027.
Ashland (ASH) SVP Converts 3,215 RSUs, Withholds 884 Shares for Tax
Ashland Inc. Senior Vice President Alessandra Faccin converted 3,215 Restricted Stock Units (RSUs) into common stock on July 27, 2026, at an indicated price of $66.38 per share. Concurrently, 884 shares were withheld to cover tax liabilities. Following this transaction, Faccin's direct equity award balance in Ashland totaled 9,646 units.
Ashland: Fiscal Q3 Earnings Snapshot
Ashland recently released its fiscal third-quarter earnings report. The summary of the report is provided, indicating key financial results for the quarter.
Ashland Releases Q3 2026 Financial Results
Ashland Inc. reported strong Q3 2026 financial results, surpassing Wall Street expectations with adjusted earnings of $1.02 per share and revenue reaching $497.0 million. The company experienced significant growth in sales volumes and its Life Sciences segment, driven by robust demand in pharmaceutical and nutraceutical applications. This positive performance reinforces Ashland's market position and highlights effective operational execution.
Ashland's Q3 Earnings Miss Estimates, Sales Beat on Volume Growth
Ashland Inc. reported its third-quarter fiscal 2026 results, with adjusted earnings of $1.02 per share missing the Zacks Consensus Estimate of $1.03. Sales, however, increased 7% year over year to $497 million, surpassing the estimate, driven by a 6% rise in sales volumes across all business units. The company reaffirmed its sales guidance for fiscal 2026 but revised its adjusted EPS outlook downward due to a higher tax rate.
Chemical maker Ashland settles with Cleveland-based activist investor Ancora
Chemical maker Ashland has reached a settlement with Cleveland-based activist investor Ancora. The article, by Bloomberg reporters Mengqi Sun, Ryan Gould, and Liana Baker, provides details of this agreement. No further information about the settlement terms or its implications is available in the provided text.
Earnings Flash (ASH) Ashland Inc. Posts Q3 Adjusted EPS $1.02 per Share, Vs. FactSet Est of $0.98
Ashland Inc. (ASH) reported its Q3 adjusted EPS of $1.02, exceeding the FactSet estimate of $0.98 per share. This indicates a stronger than anticipated financial performance for the quarter.
Ashland Inc. Stock 12‑Month Price Target Raised to $71.91, Implies 6% Upside
Eleven analysts have increased their average 12-month price target for Ashland Inc. stock from $71.09 to $71.91, implying a potential 6% upside from its closing price on July 28. The consensus rating among 12 analysts remains a "Buy," with nine recommending Buy and three suggesting Hold, signaling positive sentiment towards the stock.
Ashland Inc reports results for the quarter ended June 30 - Earnings Summary
Ashland Inc. has reported its earnings for the quarter ending June 30. The full article discussing these results is available through Reuters and other news sources on TradingView, requiring unlimited access to view the complete details.
Ashland (ASH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Ashland (ASH) reported Q3 2026 revenue of $497 million, a 7.3% increase year-over-year, surpassing the Zacks Consensus Estimate. EPS was $1.02, slightly below the estimated $1.03. The article highlights key revenue and adjusted EBITDA metrics for various segments, showing strong performance in Life Sciences and Intermediates, and notes that Ashland's stock has outperformed the S&P 500 over the past month.
Ashland (NYSE:ASH) Reports In-Line Q3 and Reaffirms Guidance as a Quality Stock
Ashland (NYSE:ASH) reported essentially in-line fiscal third-quarter results, with revenue and adjusted EPS modestly exceeding analyst expectations. The company reaffirmed its full-year sales and EBITDA guidance, though diluted EPS growth was lowered due to tax items. Life Sciences and Personal Care segments showed strong performance, contributing to a solid balance sheet and free cash flow conversion.
Ashland confirms settlement with activist Ancora Holdings (update)
Ashland Inc. has confirmed a settlement with activist investor Ancora Holdings, which will result in the addition of two new independent directors to the chemical maker's board and the creation of a capital allocation committee. This agreement aims to drive shareholder value and address activist concerns, potentially increasing focus on a sale of the company as previously suggested by Ancora. The settlement is expected to give shareholders confidence in the management's direction.
Earnings Flash (ASH) Ashland Inc. Reports Q3 Revenue $497.0M, vs. FactSet Est of $486.0M
Ashland Inc. (ASH) reported its third-quarter revenue reached $497.0 million, surpassing FactSet's estimate of $486.0 million. The company also reaffirmed its 2026 revenue outlook range between $1.84 billion and $1.87 billion, against an estimated $1.85 billion. This financial update indicates a positive Q3 revenue performance for Ashland Inc.
Ashland announces appointment of two new directors as part of Cooperation Agreement with stockholder Ancora
Ashland Inc. has announced the appointment of Peter Thomas and Allen Spizzo to its Board of Directors as independent members, effective immediately. This move is part of a cooperation agreement with stockholder Ancora Holdings Group, LLC and also includes the formation of a Capital Allocation Advisory Committee. The new committee will be chaired by Scott Tozier and will provide recommendations to the Board regarding the company’s capital allocation approach and strategic planning.
Chemical-Maker Ashland Is Said to Near Settlement With Ancora
Chemical-maker Ashland Inc. has reached a settlement agreement with activist investor Ancora Holdings Group, leading to the appointment of two new directors, Peter Thomas and Allen Spizzo, to its board. This expands the current board to 11 directors, with plans to reduce it to 10 at next year's annual shareholder meeting. The agreement confirms an earlier Bloomberg News report.
Franklin Resources (ASH) reports 3.62M-share beneficial stake in Ashland
Franklin Resources Inc. and its affiliates have reported a beneficial ownership of 3,616,479 shares of Ashland Inc. common stock, which represents 7.9% of the outstanding class. These shares are held for clients of Franklin's investment management subsidiaries, with Franklin Mutual Advisers, LLC holding the largest portion with sole voting and dispositive power over most of these shares. The filing also clarifies an internal realignment where Franklin Mutual Advisers and Brandywine Global Investment Management are now aggregated into Franklin Resources' beneficial ownership reporting as of March 31, 2026.
Ashland earnings up next as activist investors press for sale By Investing.com
Ashland Global Holdings Inc. is expected to report fiscal third-quarter earnings with analysts projecting $0.99 per share on revenue of $484.9 million. The earnings announcement comes amidst pressure from activist investors Ancora Alternatives and Cruiser Capital Advisers, who are pushing for a strategic sale of the company and threatening a proxy contest if the board does not engage. Investors will be keenly watching segment performance and management's response to the activist demands, especially given past earnings misses and operational headwinds.
Ashland: Fiscal Q3 Earnings Snapshot
Ashland Inc. reported a fiscal third-quarter net income of $16 million, or 35 cents per share, which is a significant improvement from a loss in the previous year. Although earnings, adjusted for one-time items, fell slightly short of Wall Street estimates at $1.02 per share versus an expected $1.03, the company's revenue of $497 million surpassed forecasts. Ashland anticipates full-year revenue between $1.84 billion and $1.87 billion, reflecting a positive outlook with its shares climbing 33% over the last 12 months.
Wolfe Research raises Ashland stock price target on activism
Wolfe Research has increased its price target for Ashland Inc. (NYSE:ASH) to $78, maintaining an Outperform rating, primarily due to anticipated activism campaigns. The firm expects varied performance across Ashland's business segments and has adjusted its EBITDA estimates for 2026 and 2027. Despite operational challenges, the stock is considered undervalued, and strategic discussions are ongoing with investor groups advocating for potential sales.
Ashland Inc. (ASH) Stock Price | Live Quotes & Charts | NYSE
This page provides live stock quotes and charts for Ashland Inc. (ASH) on the NYSE, showing its current price, daily change, and analyst ratings summary. The article is primarily a stock information page from Timothy Sykes' platform, which also includes disclaimers about the risks associated with day trading and references to studies on day trading profitability, suggesting that most active traders lose money.
ASH|Ashland Inc|Price:66.400|Chg%:-0.145
Ashland Inc. (ASH) closed at $66.40, down 0.22%, with its fundamentals rated healthy and growth potential high. The company's valuation is considered fairly valued in the Chemicals industry. While the stock has experienced a recent turnaround to loss and institutional selling, analysts maintain a "Buy" rating with a target price of $69.12.
ASH4041064 Bond Profile — Key Metrics
This article provides key metrics for the Ashland Inc. 6.875% 15-MAY-2043 bond, identified as ASH4041064. It details the issuer, issue and maturity dates, outstanding amount, face value, minimum denomination, and coupon rate. The profile also includes a description of Ashland, Inc.'s business segments, such as Life Sciences, Personal Care, Specialty Additives, and Intermediates.
